Treatment of acquired hemophilia A

103Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Acquired hemophilia A (AH) is an autoimmune disease that leads to potentially severe bleeding. Management relies on rapid and accurate diagnosis, control of bleeding episodes and eradication of the inhibitor by immunosuppression. There is extensive literature about the disease but only few controlled data are available. This paper reviews the current literature on treatment strategies for hemostatic therapy and inhibitor eradication. Potential future developments are discussed. © 2007 International Society on Thrombosis and Haemostasis.

Cite

CITATION STYLE

APA

Collins, P. W. (2007, May). Treatment of acquired hemophilia A. Journal of Thrombosis and Haemostasis. https://doi.org/10.1111/j.1538-7836.2007.02433.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free